Elekta is reducing the number of employees by 450

A large international study published in The Lancet, suggests that adding just five minutes of moderate-intensity activity per day – or cutting sitting time by 30 minutes – could prevent a substantial share of premature deaths.

When working, many of us sit for long periods of time, especially at desks and in front of screens.

Hansa Biopharma has announced a reorganization of its European and International Commercial and Medical Affairs operations, effective December 11, 2025.

With SEK 390 million in fresh funding and a Phase II trial in endometriosis underway, Gesynta Pharma’s CFO Michaela Gertz is navigating the financial complexities of a VC-backed biotech with precision and purpose.

As a consequence of a zero-based review of the organization, Elekta will reduce its global workforce by approximately 450 employees with a major effect on managerial positions.

On November 13, the day before the company's Extraordinary General Meeting, it was announced that Mikael Dolsten will not seek election to the Board of Directors as otherwise announced in the notice convening the meeting.

Imagine your job involves meeting with entrepreneurs and researchers who are passionate about developing drugs that could transform or save lives, and realizing you could be part of that future. That is just another “day at the office” for Ester Sklarsky, who has been a principal for the Swedish venture capital firm Sound Bioventures for the past three and a half years.